Alfasigma USA, Inc. (formerly Pamlab) is an American medical food company, and a division of Alfasigma Group, of Bologna, Italy.
Alfasigma's base of operations is located in Bedminster, New Jersey.
The company entered the pharmaceutical industry in 1957, initially introducing prescription cough/cold products. In 1987, Pamlab was purchased by Samuel and Judith Camp.[1]
In early 2013, Pamlab was purchased by Nestlé Health Science.[2]
In December 2016, Pamlab was purchased by Alfasigma Group of Bologna, Italy.[3]
Alfasigma USA, Inc. was sued by ExeGi Pharma LLC and the Italian inventor of probiotic VSL#3, Claudio De Simone, for making false advertising claims and ownership rights to VSL#3.[4] [5] [6]
According to court documents: "Defendant VSL Inc., and its licensees Alfasigma and Leadiant, having lost the right to sell the De Simone Formulation, decided to manufacture, market, and sell a different, inferior formulation (the “Fraudulent Formulation”) without conducting any tests to determine if the Fraudulent Formulation would be efficacious in any way".
A scientific article published in Frontiers in Immunology concluded: "These discrepancies may have a major impact on patient safety and on the liability of doctors when they prescribe a probiotic formulation made with different processes at different production sites from the formulation, which generated the original evidence, without properly informing the patients".[7]
A class action related to the VSL#3 scandal was recently opened in the USA.[8]
Alfasigma USA, Inc. produces medical foods for people with diabetic peripheral neuropathy, early memory loss/Alzheimer's, high-risk pregnancy, depression, and other medical conditions.
Some of Alfasigma USA's products include the following: